We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Novel Neuraminidase Inhibitor Shows Promise against H5N1 Avian Influenza Virus

By LabMedica International staff writers
Posted on 11 Mar 2010
Drug developers have shown that the novel antiviral neuraminidase inhibitor R-125489 administered as its prodrug CS-8958 works effectively against the highly pathogenic influenza A virus H5N1 (the avian influenza virus), including oseltamivir (Tamiflu)-resistant strains.

An international team of virologists and infectious disease experts from as far a field as the University of Wisconsin (Madison, USA) and the University of Kobe (Japan) reported in the February 26, 2010, online edition of the journal PLoS Pathogens that a single dose of CS-8958 given to mice two hours after infection with H5N1 influenza viruses produced a higher survival rate than did continuous five-day administration of oseltamivir. More...


Virus titers in lungs and brain were substantially lower in infected mice treated with a single dose of CS-8958 than in those treated with the five-day course of oseltamivir. Furthermore, a single dose of CS-8958 given seven days prior to virus exposure also protected mice against H5N1 virus lethal infection.

At the molecular level, the investigators found that R-125489 bound to the viral neuraminidase more tightly than did any other neuraminidase inhibitor tested. Summing up, the authors wrote that, "Our results indicate that CS-8958 is highly effective for the treatment and prophylaxis of infection with H5N1 influenza viruses, including oseltamivir-resistant mutants.”

Related Links:
University of Wisconsin
University of Kobe


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Urine Analyzer
respons® UDS100
New
Steam Sterilizer
Hi Vac II Line
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The method that profiles DNA methylation in cell-free DNA from a single blood sample to detect disease signals system-wide (photo courtesy of Shutterstock)

cfDNA Methylation Assay Enables Multi-Disease Detection from Single Blood Sample

Early, accurate detection of cancer and organ disease remains limited by cost, reliance on targeted mutation assays, and uncertainty about the signal’s tissue of origin. Many liquid biopsy approaches require... Read more

Immunology

view channel
Image: Mycobacterium tuberculosis bacteria seen with a scanning electron microscope (Credit: CDC PHIL)

Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection

Active tuberculosis (TB) remains a leading cause of death and illness worldwide, yet distinguishing contagious disease from latent infection continues to challenge clinicians. Standard screening tools... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.